Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vermeire, Severine"" wg kryterium: Autor


Tytuł :
Variability in the Distribution of Histological Disease Activity in the Colon of Patients with Ulcerative Colitis.
Autorzy :
Bossuyt P; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Gastroenterology, Imelda General Hospital, Bonheiden, Belgium.
Bisschops R; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
De Hertogh G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Apr 06; Vol. 15 (4), pp. 603-608.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
Autorzy :
Deleu S; Department of Chronic Diseases, Metabolism & Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Machiels K; Department of Chronic Diseases, Metabolism & Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Raes J; Center for Microbiology, VIB, Leuven, Belgium; Department of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium.
Verbeke K; Department of Chronic Diseases, Metabolism & Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Vermeire S; Department of Chronic Diseases, Metabolism & Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Electronic address: Severine.Vermeire@uzleuven.be.
Pokaż więcej
Źródło :
EBioMedicine [EBioMedicine] 2021 Apr 01; Vol. 66, pp. 103293. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resection.
Autorzy :
Bislenghi G; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium. .
Fieuws S; Interuniversity Center for Biostatistics and Statistical Bioinformatics, University of KU Leuven, Leuven, Belgium.; University of Hasselt, Leuven, Hasselt, Belgium.
Wolthuis A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Vanbeckevoort D; Department of Radiology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Sabino J; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
D'Hoore A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
International journal of colorectal disease [Int J Colorectal Dis] 2021 Apr; Vol. 36 (4), pp. 791-799. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
Autorzy :
Rivière P; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Irles-Depe M; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Van Assche G; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Rutgeerts P; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Denost Q; Department of Abdominal Surgery, Haut-Lévêque Hospital, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Wolthuis A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
D'Hoore A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Laharie D; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Apr; Vol. 19 (4), pp. 713-720.e1. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
Autorzy :
Liefferinckx C; Department of Gastroenterology, Hôpital Erasme, ULB, Brussels, Belgium.
Bottieau J; Department of Electrical Engineering, University of Mons, Mons, Belgium.
Toubeau JF; Department of Electrical Engineering, University of Mons, Mons, Belgium.
Thomas D; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Rahier JF; Department of Gastroenterology, CHU UCL Namur, Yvoir, Belgium.
Louis E; Department of Gastroenterology, Centre Hospitalier Universitaire Sart-Tilman, ULG, Liège, Belgium.
Baert F; Department of Gastroenterology, AZ Delta, Roeselare-Menen-Torhout, Belgium.
Dewint P; Department of Gastroenterology, AZ Maria Middelares, Ghent, Belgium.; Department of Gastroenterology, UZ Antwerp, Antwerp, Belgium.
Pouillon L; Department of Gastroenterology, Imelda General Hospital, Bonheiden, Belgium.
Lambrecht G; Department of Gastroenterology, AZ Damiaan, Oostende, Belgium.
Vallée F; Department of Electrical Engineering, University of Mons, Mons, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Bossuyt P; Department of Gastroenterology, Imelda General Hospital, Bonheiden, Belgium.
Franchimont D; Department of Gastroenterology, Hôpital Erasme, ULB, Brussels, Belgium.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Mar 30. Date of Electronic Publication: 2021 Mar 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways.
Autorzy :
Prins MM; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location AMC, Amsterdam, Netherlands.
Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Translational Research Center for Gastrointestinal Disorders [TARGID], Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], KU Leuven, Leuven, Belgium.
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Translational Research Center for Gastrointestinal Disorders [TARGID], Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], KU Leuven, Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Translational Research Center for Gastrointestinal Disorders [TARGID], Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], KU Leuven, Leuven, Belgium.
Wildenberg ME; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location AMC, Amsterdam, Netherlands.; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Amsterdam, Netherlands.
Koelink PJ; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location AMC, Amsterdam, Netherlands.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Mar 15; Vol. 12, pp. 627535. Date of Electronic Publication: 2021 Mar 15 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
Autorzy :
Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Verstockt S; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Abdu Rahiman S; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Ke BJ; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Arnauts K; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.; Department of Development and Regeneration, Stem Cell Institute Leuven [SCIL], KU Leuven, Leuven, Belgium.
Cleynen I; Department of Human Genetics, Laboratory for Complex Genetics, KU Leuven, Leuven, Belgium.
Sabino J; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Matteoli G; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], Translational Research Center for Gastrointestinal Disorders [TARGID], KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Mar 05; Vol. 15 (3), pp. 485-498.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Let Food Be Thy Medicine-Its Role in Crohn's Disease.
Autorzy :
Wellens J; Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium.
Sabino J; Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2021 Mar 03; Vol. 13 (3). Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial.
Autorzy :
Vermeire S; Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: Severine.Vermeire@uzleuven.be.
Hébuterne X; Department of Gastroenterology and Clinical Nutrition, CHU of Nice, University Côte d'Azur, Nice, France.
Tilg H; Department of Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria.
De Hertogh G; Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Gineste P; Department of Pathology, University Hospitals Leuven, Leuven, Belgium(5)Abivax, Paris, France.
Steens JM; Department of Pathology, University Hospitals Leuven, Leuven, Belgium(5)Abivax, Paris, France.
Pokaż więcej
Corporate Authors :
ABX464 Investigators
Źródło :
Gastroenterology [Gastroenterology] 2021 Mar 02. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis.
Autorzy :
De Salvo C; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Buela KA; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Creyns B; Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, and.; Department of Chronic Diseases, Metabolism and Aging, TARGID, University Hospitals, KU Leuven, Leuven, Belgium.
Corridoni D; Department of Medicine and.; Department of Digestive Health Research Institute, Case Western Reserve University, Cleveland, Ohio, USA.
Rana N; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Wargo HL; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Cominelli CL; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Delaney PG; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Rodriguez-Palacios A; Department of Medicine and.; Department of Digestive Health Research Institute, Case Western Reserve University, Cleveland, Ohio, USA.
Cominelli F; Department of Medicine and.; Department of Digestive Health Research Institute, Case Western Reserve University, Cleveland, Ohio, USA.
Vermeire S; Department of Chronic Diseases, Metabolism and Aging, TARGID, University Hospitals, KU Leuven, Leuven, Belgium.; Department of Gastroenterology, University Hospitals, KU Leuven, Leuven, Belgium.
Pizarro TT; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Medicine and.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Mar 01; Vol. 131 (5).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
Autorzy :
Verstockt S; Translational Research Center for GastroIntestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium.
Verstockt B; Translational Research Center for GastroIntestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium.; University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium.
Machiels K; Translational Research Center for GastroIntestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium.
Vancamelbeke M; Translational Research Center for GastroIntestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium.
Ferrante M; Translational Research Center for GastroIntestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium.; University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium.
Cleynen I; Laboratory for Complex Genetics, Department of Human Genetics, Leuven, Belgium.
De Hertogh G; Department of Morphology and Molecular Pathology, University Hospitals, Leuven, Belgium.; Department of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.
Vermeire S; Translational Research Center for GastroIntestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium.; University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Feb 24. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases.
Autorzy :
Kantasiripitak W; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.
Alsoud D; Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.
Lobatón T; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium.
Thomas D; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Gils A; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.; Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.
Dreesen E; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Feb 19. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-term safety and efficacy of the anti-MAdCAM-1 monoclonal antibody ontamalimab (SHP647) for the treatment of ulcerative colitis: the open-label study TURANDOT II.
Autorzy :
Reinisch W; Medical University of Vienna, Vienna, Austria.
Sandborn WJ; University of California San Diego, La Jolla, CA, USA.
Danese S; Humanitas University, Milan, Italy.
Hébuterne X; University of Nice Sophia Antipolis, CHU of Nice, Nice, France.
Kłopocka M; Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Tarabar D; Clinic of Gastroenterology and Hepatology, Military Medical Academy, Belgrade, Serbia.
Vaňásek T; Charles University Hospital, Hradec Králové, Czech Republic.
Greguš M; Gastroenterology Centre, Nitra, Slovakia.
Hellstern PA; Nature Coast Clinical Research, Inverness, FL, USA.
Kim JS; Seoul National University College of Medicine, Seoul, South Korea.
Sparrow MP; Alfred Hospital, Melbourne, VIC, Australia.
Gorelick KJ; Zymo Consulting Group, Newtown Square, PA, USA.
Hoy M; Shire, a Takeda company, Lexington, MA, USA.
Goetsch M; Shire, a Takeda company, Zug, Switzerland.
Bliss C; Shire, a Takeda company, Lexington, MA, USA.
Gupta C; Cytel Inc, Cambridge, MA, USA.
Cataldi F; Shire, a Takeda company, Lexington, MA, USA.
Vermeire S; University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Feb 18. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus.
Autorzy :
Carels C; Pediatric Gastroenterology, UZ Brussels, Jette, Belgium.
Wauters L; Gastroenterology and Hepatology, University Hospitals, KU Leuven, Leuven, Belgium.
Outtier A; Gastroenterology and Hepatology, University Hospitals, KU Leuven, Leuven, Belgium.
Baert F; Gastroenterology, AZ Delta, Roeselare, Belgium.
Bossuyt P; Gastroenterology, Imelda Ziekenhuis, Bonheiden, Belgium.
Colard A; Gastroenterology, CHC Liège, Liège, Belgium.
De Looze D; Gastroenterology and Hepatology, UZ Gent, Ghent, Belgium.
Ferrante M; Gastroenterology and Hepatology, University Hospitals, KU Leuven, Leuven, Belgium.
Goegebuer A; Gastroenterology, Heilig Hart Ziekenhuis Leuven, Leuven, Belgium.
Hauser B; Pediatric Gastroenterology, UZ Brussels, Jette, Belgium.
Hilbrands R; Diabetes Clinic, UZ Brussel, Jette, Belgium.
Hoffman I; Pediatric Gastroenterology, University Hospitals, KU Leuven, Leuven, Belgium.
Keymeulen B; Diabetes Clinic, UZ Brussel, Jette, Belgium.
Paquot I; Pediatric Gastroenterology, CHC Liège, Liège, Belgium.
Ruytjens I; Gastroenterology, ZNA Middelheim, Antwerp, Belgium.
Simoens M; Gastroenterology, ZNA Jan Palfijn, Merksem, Belgium.
Thienpont C; Gastroenterology, ZNA Stuivenberg, Antwerp, Belgium.
Verreth A; Gastroenterology, AZ Sint-Jozef, Malle, Belgium.
Verstockt B; Gastroenterology and Hepatology, University Hospitals, KU Leuven, Leuven, Belgium.
Vermeire S; Gastroenterology and Hepatology, University Hospitals, KU Leuven, Leuven, Belgium.
Veereman G; Pediatric Gastroenterology, UZ Brussels, Jette, Belgium.
Pokaż więcej
Źródło :
Frontiers in pediatrics [Front Pediatr] 2021 Feb 05; Vol. 9, pp. 624416. Date of Electronic Publication: 2021 Feb 05 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inflammatory bowel disease and Parkinson's disease: common pathophysiological links.
Autorzy :
Lee HS; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lobbestael E; Laboratory for Neurobiology and Gene Therapy, KU Leuven, Leuven, Belgium.
Vermeire S; Department of Chronic diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Sabino J; Department of Chronic diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Cleynen I; Department of Human Genetics, KU Leuven, Leuven, Belgium .
Pokaż więcej
Źródło :
Gut [Gut] 2021 Feb; Vol. 70 (2), pp. 408-417. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
Autorzy :
Bossuyt P; Department of Gastroenterology, Imelda GI Clinical Research Center, Imelda General Hospital, Bonheiden, Belgium; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Catholic University of Leuven, Leuven, Belgium. Electronic address: .
Dreesen E; Department of Pharmaceutical and Pharmacological Sciences, Catholic University of Leuven, Leuven, Belgium.
Rimola J; IBD Unit, Radiology Department, Hospital Clínic of Barcelona, Barcelona, Spain.
Devuysere S; Department of Radiology, Imelda General Hospital, Bonheiden, Belgium.
De Bruecker Y; Department of Radiology, Imelda General Hospital, Bonheiden, Belgium.
Vanslembrouck R; Department of Radiology, University Hospitals Leuven, Catholic University of Leuven, Leuven, Belgium.
Laurent V; INSERM U947 and Department of Radiology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
Zappa M; Department of Radiology, Beaujon Hospital, Clichy, France.
Savoye-Collet C; Department of Radiology, Rouen University Hospital, Normandy University, UNIROUEN, Rouen, France.
Pariente B; Department of Gastroenterology, Hospital Claude Huriez, Lille, France.
Filippi J; Department of Gastroenterology, Hospital Archet, Nice, France.
Baert F; Department of Gastroenterology, AZ Delta, Roeselare, Belgium.
D'Haens G; Department of Gastroenterology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Laharie D; Department of Gastroenterology, Hôpital Haut-Lévêque, Bordeaux University Hospital, Pessac, France.
Peyrin-Biroulet L; INSERM U1256 NGERE and Department of Hepato-Gastroenterology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Catholic University of Leuven, Leuven, Belgium.
Pokaż więcej
Corporate Authors :
TAILORIX study group
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 May; Vol. 19 (5), pp. 947-954.e2. Date of Electronic Publication: 2020 Apr 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
PPIs and anti-TNF in patients with IBD: a forbidden combination?
Autorzy :
Wellens J; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium .; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.
Sabino J; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium.; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.; Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium.
Vermeire S; Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.; Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium.
Pokaż więcej
Źródło :
Gut [Gut] 2021 Jan 29. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.
Autorzy :
Vermeire S; Department of Gastroenterology & Hepatology, University Hospitals Leuven, Leuven, Belgium.
Chiorean M; Division of Gastroenterology, Virginia Mason Medical Center, Seattle, WA, USA.
Panés J; Department of Gastroenterology, Hospital Clinic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Peyrin-Biroulet L; Department of Gastroenterology, Nancy University Hospital, Nancy, France, and INSERM U1256 NGERE, Lorraine University, Nancy, France.
Zhang J; Arena Pharmaceuticals, Inc., San Diego, CA, USA.
Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Lazin K; Arena Pharmaceuticals, Zug, Switzerland.
Klassen P; Arena Pharmaceuticals, Inc., San Diego, CA, USA.
Naik SU; Arena Pharmaceuticals, Inc., San Diego, CA, USA.
Cabell CH; Arena Pharmaceuticals, Inc., San Diego, CA, USA.
Sandborn WJ; University of California San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Jan 21. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.
Autorzy :
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Feagan BG; Western University, London, Ontario, Canada.
Hanauer S; Feinberg School of Medicine, Chicago, IL, USA.
Vermeire S; University of Leuven, Leuven, Belgium.
Ghosh S; University of Calgary, Alberta, Canada.
Liu WJ; Bristol-Myers Squibb, Princeton, NJ, USA.
Petersen A; Bristol-Myers Squibb, Princeton, NJ, USA.
Charles L; Bristol-Myers Squibb, Princeton, NJ, USA.
Huang V; Bristol-Myers Squibb, Princeton, NJ, USA.
Usiskin K; Bristol-Myers Squibb, Princeton, NJ, USA.
Wolf DC; Center for Crohn's Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, GA, USA.
D'Haens G; Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Jan 13. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Vedolizumab treatment persistence and safety in a 2-year data analysis of an extended access programme.
Autorzy :
Danese S; Department of Biomedical Sciences, Humanitas Clinical and Research Center, IRCCS, Humanitas University, Milan, Italy.
Subramaniam K; Gastroeneterology and Hepatology Unit, Canberra Hospital, Canberra, ACT, Australia.
Van Zyl J; Gastroenterology Unit, University of the Free State, Bloemfontein, South Africa.
Adsul S; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Lindner D; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Roth J; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jan; Vol. 53 (2), pp. 265-272. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Data Analysis*
Antibodies, Monoclonal, Humanized/adverse effects ; Gastrointestinal Agents/adverse effects ; Humans ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies